Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) shares traded up 8% during mid-day trading on Wednesday . The stock traded as high as $35.63 and last traded at $35.54. 114,090 shares were traded during mid-day trading, a decline of 82% from the average session volume of 650,629 shares. The stock had previously closed at $32.91.
Analyst Upgrades and Downgrades
TRUP has been the subject of several recent analyst reports. Piper Sandler cut their price target on Trupanion from $57.00 to $52.00 and set an “overweight” rating for the company in a research note on Thursday, February 20th. Stifel Nicolaus lowered their price target on shares of Trupanion from $44.00 to $41.00 and set a “hold” rating on the stock in a research report on Thursday, February 20th. Two research analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $46.60.
Read Our Latest Research Report on TRUP
Trupanion Stock Up 4.4 %
Trupanion (NASDAQ:TRUP – Get Free Report) last announced its quarterly earnings data on Wednesday, February 19th. The financial services provider reported $0.04 EPS for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.02). Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. The firm had revenue of $337.31 million for the quarter, compared to analysts’ expectations of $335.41 million. On average, sell-side analysts expect that Trupanion, Inc. will post 0.13 EPS for the current year.
Insiders Place Their Bets
In other Trupanion news, CFO Fawwad Qureshi sold 1,373 shares of the firm’s stock in a transaction dated Wednesday, February 26th. The shares were sold at an average price of $34.22, for a total transaction of $46,984.06. Following the sale, the chief financial officer now directly owns 2,416 shares of the company’s stock, valued at $82,675.52. This trade represents a 36.24 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Margaret Tooth sold 4,000 shares of the stock in a transaction on Thursday, March 20th. The stock was sold at an average price of $37.17, for a total value of $148,680.00. Following the transaction, the chief executive officer now directly owns 118,784 shares in the company, valued at approximately $4,415,201.28. This represents a 3.26 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 29,792 shares of company stock worth $989,442. 5.50% of the stock is owned by corporate insiders.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently modified their holdings of the stock. Balyasny Asset Management L.P. increased its position in Trupanion by 368.2% during the fourth quarter. Balyasny Asset Management L.P. now owns 841,254 shares of the financial services provider’s stock worth $40,548,000 after purchasing an additional 661,559 shares during the last quarter. BNP Paribas Financial Markets grew its stake in shares of Trupanion by 170.7% during the 4th quarter. BNP Paribas Financial Markets now owns 337,093 shares of the financial services provider’s stock valued at $16,248,000 after buying an additional 212,545 shares during the period. Freestone Grove Partners LP acquired a new stake in shares of Trupanion during the 4th quarter worth $7,776,000. Baillie Gifford & Co. raised its position in shares of Trupanion by 26.6% in the 4th quarter. Baillie Gifford & Co. now owns 701,366 shares of the financial services provider’s stock worth $33,806,000 after buying an additional 147,341 shares during the period. Finally, First Trust Advisors LP acquired a new position in Trupanion in the fourth quarter valued at $7,083,000.
About Trupanion
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Further Reading
- Five stocks we like better than Trupanion
- What is the FTSE 100 index?
- Is Alphabet a Generational Buying Opportunity at These Levels?
- Using the MarketBeat Dividend Yield Calculator
- Is Microsoft Stock Too Cheap to Ignore After Its Latest Drop?
- How to Plot Fibonacci Price Inflection Levels
- Why Markets Suddenly See Opportunity in These Emerging Markets
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.